Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2606414 is an oral-available and specific PERK inhibitor (IC50=0.4 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 61.00 | |
5 mg | In stock | $ 95.00 | |
10 mg | In stock | $ 129.00 | |
50 mg | In stock | $ 349.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | GSK2606414 is an oral-available and specific PERK inhibitor (IC50=0.4 nM). |
Targets&IC50 | EIF2AK3 (PERK):0.4 nM |
Molecular Weight | 451.44 |
Formula | C24H20F3N5O |
CAS No. | 1337531-36-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45.1 mg/mL (100 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2606414 1337531-36-8 Apoptosis Autophagy PERK Inhibitor GSK-2606414 PKR-like endoplasmic reticulum kinase GSK 2606414 inhibit Protein kinase R-like endoplasmic reticulum kinase inhibitor